High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum B-lactam drugs in intensive care units

Diagnostic Microbiology and Infectious Disease

Volumn 36, Issue 1, 2000, Pages 53-56

  Shehabia, Asem A ^a   Mahafzah, Azmi ^a   Baadran, Izdiad ^a   Qadar, Fouad A ^a   Dajani, Naheel ^a  

^a JORDAN UNIVERSITY HOSPITAL   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; IMIPENEM; PIPERACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CONTROLLED STUDY; ENTEROBACTER; ESCHERICHIA COLI; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

AZTREONAM; BETA-LACTAM RESISTANCE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CROSS INFECTION; GRAM-NEGATIVE BACTERIA; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; JORDAN; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LACTAMS; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0033966258     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(99)00108-X     Document Type: Article

References (23)

1. Arbo J., Hariharan R., Nathan C., et al. Utility of serial rectal swab cultures for detection of ceftazidime- and imipenem-resistant Gram-negative bacilli from patients in the intensive care unit. Eur J Clin Microbiol Infect Dis. 17:1998;727-730.
2. Cormican M.G., Marshall S.A., Jones R.N. Detection of extended-spectrum B-lactamase (ESBL)-producing stains by Etest ESBL screen. J Clin Microbiol. 34:1996;1880-1884.
3. Jones R.N., Salazar J.C., Pfaller M.A., et al. Multicenter evaluation of the antimicrobial activity for six broad-spectrum B-lactamas in Colombia using the Etest method. Colombian Antimicrobial Resistance Study Group. Diag Microbial Infect Dis. 29:1997;265-272.
4. Dominique L.M., James W.B., Jonathan R.E., et al. Evidence of interhospital transmission of extended-spectrum B-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. Infect Control Hosp Epidemiol. 18:1997;429-498.
5. Pfaller M.A., Jones R.N., Doern G.V. Multicenter evaluation of the antimicrobial activity for six broad-spectrum b-lactams in Venezuela using the Etest method. The Venezuelan Antimicrobial Resistance Study Group. Diagn Microbiol Infect Dis. 30:1998;45-52.
6. Goetz A., Yu V.L. The intensive care unit the hot-test zone . Curr Opin Infect Dis. 10:1997;319-323.
7. Hanberger H., Garcia-Rodriquez J.A., Gobernado M., et al. Antibiotic susceptibility among aerobic Gram-negative bacilli in intensive care units in 5 European countries. JAMA. 281:1999;67-71.
8. Hyunjoo P., Lyu S., Lee J., et al. Survey of extended-spectrum B-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae prevalence of TEM-52 in Korea . J Clin Microbiol. 37:1999;1758-1763.
9. Itokazo G.S., Quinn J.P., Bell-Dixon C., et al. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units. Evaluation of a national post marketing surveillance program. Clin Infect Dis. 23:1996;779-784.
10. Liu Y.P., Tung J.C., Ke S.C., Chen S.L. Molecular epidemiology of extended-spectrum B-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan. J Clin Microbiol. 36:1998;2759-2762.
11. Livermore D.M., Yuan M. Antibiotic resistance and production of extended-spectrum B-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother. 38:1996;409-424.
12. Jacoby, G. A. & Han, P. C. (1996). Detection of extended-spectrum B-lactamases in clinical isolates of Klebsiella pneumoniae and E. coli. J Clin Microbiol 34, 908-911.
13. Moosdeen F. The evaluation of resistance to cephalosporins. Clin Infect Dis. 29:1997;487-493.
14. National Committee for Clinical Standards (NCCLS). (1995). Performance standards for antimicrobial disk susceptibility tests, 5th ed. Approved standard M2-A5. National Committee for Clinical Standards, Villanova, PA.
15. National Committee for Clinical Standards (NCCLS). (1997). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A4. National Committee for Clinical Standards, Villanova, PA.
16. Olivier G., Maruejouls C., Abachin E., et al. Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum B-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol. 36:1998;1357-1360.
17. Quinn, P. J., Miyashiro, D., & Sahm, D., et al. (1989). Novel plasmid-mediated B-lactamase (TEM-10) conferring selective resistance to ceftazidime and Aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 33, 1451-1456.
18. Rahal J., Urban C., Horn D., et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 280:1998;1233-1237.
19. Rice L.B., Eckstein E.C., Devente J., Shlaes D.M. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis. 23:1996;118-124.
20. Shannon K., Stapleton P., Xiang X., et al. Extended-spectrum B-lactamase producing nosocomial outbreaks of infection in the United Kingdom. J Clin Microbiol. 36:1998;3105-3110.
21. Shehabi A.A., Baadran I. Microbial infection and antibiotic resistance patterns among Jordanian intensive care patients. Eastern Mediterran Health J. 2:1996;515-520.
22. Thomson K.S., Prevan A.M., Sander C.C. Novel plasmid mediated B-lactamases in enterobacteriaceae emerging problems of new B-lactam antibiotics . Curr Clin Top Infect Dis. 16:1996;151-163.
23. Wiener J., Quinn J.P., Brandford P.A., et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA. 281:1999;517-523.